Send us Feedback

Alexza Pharmaceuticals (ALXA)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ALXA » Topics » Statement of Financial Accounting Standard No. 157

These excerpts taken from the ALXA 10-K filed Mar 17, 2008.
Statement of Financial Accounting Standard No. 157
 
In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements (“SFAS 157”). SFAS 157 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles, and expands disclosures about fair value measurements. The provisions of SFAS 157 are effective for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. Management is currently evaluating the impact of the provisions of SFAS 157 on its financial position, results of operations and cash flows but does not believe the impact of the adoption will be material.
 
Statement
of Financial Accounting Standard No. 157


 



In September 2006, the FASB issued SFAS No. 157,
Fair Value Measurements (“SFAS 157”).
SFAS 157 defines fair value, establishes a framework for
measuring fair value in accordance with generally accepted
accounting principles, and expands disclosures about fair value
measurements. The provisions of SFAS 157 are effective for
financial statements issued for fiscal years beginning after
November 15, 2007, and interim periods within those fiscal
years. Management is currently evaluating the impact of the
provisions of SFAS 157 on its financial position, results
of operations and cash flows but does not believe the impact of
the adoption will be material.


 




EXCERPTS ON THIS PAGE:

10-K (2 sections)
Mar 17, 2008

RELATED TOPICS for ALXA:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki